Needham downgrades Biogen on slow growth of Alzheimer's drug
Go back to Needham downgrades Biogen on slow growth of Alzheimer's drug| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 218.12 +1.34 (0.62%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $216.78 | 52 Week High | $333.65 | |||
| Open | $216.40 | 52 Week Low | $223.02 | |||
| Day High | $218.50 | P/E | 27.93 | |||
| Day Low | $213.96 | EPS | $7.81 | |||
| Volume | 649,817 | |||||

